PubMed Health⌕ Search

PubMed · 14983132

[Dose evaluation of a flat-panel detector system].

Abstract

We compared the INNOVA2000 (INNOVA), which has a flat panel detector system, and the Advantx LCLP (LCLP), which has a conventional I. I. system, in terms of the dependence of phantom thickness on patient surface dose (surface dose) and receptor entrance dose (entrance dose). We examined the reduction in surface dose and entrance dose by using an additional filter and shortening the patient detector distance (PDD). The surface dose rate for fluoroscopy with INNOVA was 73.8-63.5%, and the reduction rate was high at a phantom thickness of less than 20 cm compared with LCLP, but such a reduction could not be expected at a phantom thickness of more than 30 cm, depending on maximum dose rate. The rate of reduction in surface dose in the case of exposure was considerably low at a phantom thickness of about 20 cm, while the other's (5, 10, 15, 25, 30 cm) reduction rates were about 40%. The length of PDD with INNOVA was shortened by 5 cm compared with LCLP. As a result, we obtained a reduction rate of surface dose of 11-15%, while the entrance dose was 10% lower. The reduction rate achieved with an additional filter was 43-60% in surface dose rate in fluoroscopy, whereas that of surface dose for exposure was about 50% at phantom thicknesses up to 20 cm, but remained just 25% thereafter. The results indicated that the reduction of surface dose with INNOVA could be changed by means of the phantom thickness, and we consider the effect achieved by the addition of a filter to be the main factor.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sigenobu Seguchi, Yoshinobu Ishikawa, Shouta Mizuno, Takaya Saijou, Tatsuji Nagao, Akirou Nakamura. 2003. [Dose evaluation of a flat-panel detector system].. https://doi.org/10.6009/jjrt.kj00003174076

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Sleep apnoea and hypertension: role of chemoreflexes in humans.

The link between sleep apnoea and systemic hypertension in humans is well documented. However, a direct causal association between the two diseases independent of comorbidities has been difficult to establish. Comorbidities clearly play an important role in this strong relationship; however, new findings also suggest that sleep apnoea is an independent risk factor for hypertension. This relationship appears to be at least in part a result of chronically elevated sympathetic activity, and therefore manifests as a neurally mediated hypertension. Although the mechanism(s) for this causal relationship of sleep apnoea to hypertension remains ill defined, a growing body of literature suggests that autonomic dysfunction, mediated by abnormal chemoreflex control of sympathetic activity, is a potential mechanism. Abnormal chemoreflex responses to both acute and chronic apnoea or hypoxia have been demonstrated. Hypothesized mechanisms by which chemoreflex dysfunction may contribute to chronically elevated sympathetic tone and ultimately hypertension are explored in this review. Thus, this review focuses on the current evidence linking chemoreflex function to obstructive sleep apnoea and systemic hypertension in humans and provides an analysis of these data and their implications.

Cardiovascular System↗

Gender differences in drug responses.

This review summarizes gender differences (GDs) in drug response. Although GDs have been described both in pharmacodynamics and pharmacokinetics, their role in clinical practice is not yet completely elucidated. The evidence that women have been less enrolled in clinical trials and that a gender-specific analysis usually is not included in the evaluation of results, contributes largely to this uncertainty. Consequently, adverse drug reactions (ADRs) are still higher in females than in males. Since sex is a fundamental biological variable that cannot be discounted, GDs in pharmacology have to be considered in order to improve drug safety efficacy and to optimize medical therapy both in men and women.

Cardiovascular System↗